WO2001058408A2 - Medicament polyvalent et systeme de thermotherapie - Google Patents

Medicament polyvalent et systeme de thermotherapie Download PDF

Info

Publication number
WO2001058408A2
WO2001058408A2 PCT/US2001/003432 US0103432W WO0158408A2 WO 2001058408 A2 WO2001058408 A2 WO 2001058408A2 US 0103432 W US0103432 W US 0103432W WO 0158408 A2 WO0158408 A2 WO 0158408A2
Authority
WO
WIPO (PCT)
Prior art keywords
treatment system
group
heat
system defined
holding member
Prior art date
Application number
PCT/US2001/003432
Other languages
English (en)
Other versions
WO2001058408A3 (fr
Inventor
Israel Dvoretzky
John E. Kuleza
Original Assignee
Israel Dvoretzky
Kuleza John E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Israel Dvoretzky, Kuleza John E filed Critical Israel Dvoretzky
Priority to DE60112248T priority Critical patent/DE60112248T2/de
Priority to EP01908795A priority patent/EP1255519B1/fr
Priority to CA002398543A priority patent/CA2398543A1/fr
Priority to AU36627/01A priority patent/AU778280B2/en
Priority to AT01908795T priority patent/ATE300262T1/de
Publication of WO2001058408A2 publication Critical patent/WO2001058408A2/fr
Publication of WO2001058408A3 publication Critical patent/WO2001058408A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001—Body part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0225—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0261—Compresses or poultices for effecting heating or cooling medicated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F7/03—Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction
    • A61F7/032—Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction using oxygen from the air, e.g. pocket-stoves
    • A61F7/034—Flameless
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • This invention relates to a treatment system for a wide variety of medical problems providing and, more particularly, to a treatment system combining an exothermic pad with holding means for providing controlled, reproducible, continuous heat delivery to the surface of the skin or subcutaneously at a substantially constant temperature for specific periods of time in order to enable medicinal heat benefits to be realized.
  • warts One of the prime examples of a medical condition that has recently been found to be treatable with heat therapy is warts .
  • the present invention is not limited to warts, the efficacy of using heat for wart treatment is detailed herein as an example of the benefit of the present invention.
  • Warts are very common viral induced growths (infectious process) and have long presented problems to individuals due to the pain, discomfort and the cosmetic problems associated therewith. Although various methods and treatments have been developed over the years for reducing or eliminating the undesirable effects associated with warts, these prior art applications, treatments and methods have been incapable of eliminating or curing warts or the problems associated with them.
  • the skin is divided into three layers, the epidermis, the dermis, and the subcutaneous tissue.
  • the outer layer of the skin is called the epidermis, and varies in thickness from about 0.3 mm on the eyelids and flexural areas to 1.55 mm on the palms and soles.
  • the outermost layer of the epidermis is the stratum corneum (horny layer), which is comprised of completely keratinized dead cells. The thickness of the stratum corneum varies greatly on different parts of the body, being thickest on the palms and soles and totally absent on the oral mucosa.
  • the bottommost layer of the epidermis rests upon the basement membrane separating the epidermis from the dermis.
  • the basel cells are the epidermal cells that proliferate.
  • the basal cells proliferate and, by cell division, form the keratinocytes (squamous cell layer, stratum spinosum, spinous layer).
  • the keratinocytes synthesize insoluble protein which remains in the cells and will eventually become a major component of the outer layer (the stratum corneum, horny layer).
  • the keratinocytes continue to divide and to migrate from the bottommost layer to the outermost layer, until the cells finally die.
  • Warts are known to be intra-epidermal tumors of the skin caused by infection with the human papilloma virus (HPN).
  • HPN human papilloma virus
  • the HPN induces an abnormal increase of cells in the skin tissue, commonly referred to as hyperplasia, with the hyperplasia being limited to the squamous epithelium.
  • replication of the papilloma virus is confined to the nuclei of the upper layer of infected epidermal cells.
  • Many different methods and application systems have been developed to treat warts.
  • viruses prefer to produce lesions on the acral (end) parts of the body which are cooler than the rest of the body. Since the skin surface in general and the extremities of individuals, such as hands and feet, typically have temperatures of between about 24° and 31 °C , (less than the body temperature) these locations are typical for the development of the wart virus. In contrast, the anogenital warts and laryngeal warts tend to replicate in more warmer locations and are clearly well known as comprising a different HPN types. Narious studies have shown that the local application of heat causes the virus organisms to be slowed or inactivated.
  • hot water baths are extremely difficult to employ since the entire body part, not only the wart, must be immersed into the hot water. This is particularly difficult since long time exposures are required, as well as repeated exposures several times a day. Furthermore, the hot water bath procedure is particularly hazardous to children due to the risk of severe burning.
  • warts exemplify the numerous conditions that can be effectively treated if a dependable delivery system for providing heat therapy were available. Similarly, these numerous other medical problems are also effectively treated using a similar dependable delivery system which provides controlled heat therapy.
  • Another object of the present invention is to provide a treatment system having the characteristic features described above which is capable of being constructed as a single-use system which is easily applied to the skin surface for attaining the desired heat benefits and then disposed after use.
  • Another object of the present invention is to provide a treatment system having the characteristic features described above which is capable of providing consistent, repeatable, reproducible, and reliable temperature levels in a convenient, easily attained, safe manner.
  • a treatment system which comprises, at a minimum, a fully integrated, easily employed holding or support member which is uniquely constructed for cooperating with a heat delivery patch or exothermic pad for optimizing the application of heat directly to a precisely desired location.
  • a heat delivery patch or exothermic pad for optimizing the application of heat directly to a precisely desired location.
  • medical conditions such as psoriasis, skin cancers, warts, leishmaniasis, mycobacteria, and granuloma annulare can be treated or improved by heat penetration into the skin, subcutaneous tissues, joints, muscles, blood streams, etc.
  • heat has been found to slow, inhibit, or reverse metabolic processes, immunological processes, or biological conditions or processes which depend upon heat or are affected by heat.
  • numerous medical conditions are effectively treated by employing the integrated treatment system of the present invention. It has also been found that the use of heat produces a positive, synergistic effect on the targeted, controlled delivery of predetermined amounts of drugs, penetration enhancing agents, and/or cosmetics.
  • the topical use of drugs, penetration enhancing agents, and/or cosmetics for the treatment of skin conditions and/or subcutaneous symptoms including, but not limited to, pain, itch, and irritations are improved or effectively treated by the use of the present invention.
  • the delivery of drugs, penetration enhancing agents and/or cosmetics through the skin for the purpose of achieving a non-oral and/or non- parenteral, systemic, transdermal delivery is effectively enhanced by the presence of a controlled heat gradient.
  • Exothermic pads or heat delivery patches have been previously developed and typically comprise a porous film or pad of woven or non-woven material incorporating chemicals which will react exothermically to generate heat in the presence of oxygen.
  • exothermic pads or heat delivery patches typically contain moxa or a mixture of iron powder, activated charcoal, wood fibers, water and salt.
  • a mixture of alkaline sulfides and iron carbide are employed with the chemicals stored in an inert, oxygen-free, chamber to prevent exposure to oxygen prior to use.
  • the pores of the pad are of sufficient size to assure that the required air flow is achieved.
  • the patch/pad Prior to use, the patch/pad is typically sealed within a pouch with an inert gas, such as nitrogen. As long as the patch/pad remains in the sealed container until use, no chemical reaction takes place. However, once the pouch is open, the presence of the oxygen in the air causes the chemicals to react and the desired exothermic reaction is produced.
  • an inert gas such as nitrogen
  • the exothermic pad or heat delivery patch is separately employed by having the user place the pad or patch on the desired site where heat treatment is being sought.
  • the heat delivery patch or exothermic pad is separately secured to the desired site by adhesive means associated therewith.
  • any desired securement method may be employed.
  • the use of a heat gradient as provided by the fully integrated treatment system of the present invention is effective, improving and enhancing the penetration of systemic and topical medications such as corticosteroids, chemotherapeutic agents, anesthetics, antihistamines, anti-infectives, anti-bacterials, anti-parasitics, anti-viral agents, anti- oxidants, immunomodulators, keratolytics, and anti-neoplasties.
  • systemic and topical medications such as corticosteroids, chemotherapeutic agents, anesthetics, antihistamines, anti-infectives, anti-bacterials, anti-parasitics, anti-viral agents, anti- oxidants, immunomodulators, keratolytics, and anti-neoplasties.
  • systemic and topical medications such as corticosteroids, chemotherapeutic agents, anesthetics, antihistamines, anti-infectives, anti-bacterials, anti-parasitics, anti-viral
  • corticosteroids may comprise one or more selected from the group consisting of hydrocortisone, triamcinolone, betamethasone, and any other steroids commonly used in topical applications to the skin;
  • chemothera-peutic agents may comprise one or more selected from the group consisting of 5FU, Bleomycin, cytotoxic agents;
  • anesthetics may comprise one or more selected from the group consisting of lidocaine, prilocaine, and pramoxine;
  • antihistamines may comprise one or more selected from the group consisting of diphenhydramine and its salts;
  • anti- infectives, such as anti-fungals may comprise one or more selected from the group consisting of clotrimazole and ciclopirox;
  • anti-bacterials may comprise one or more selected from the group consisting of gentamicin, tetracycline, erythromycin, and clindamycin;
  • anti-parasitics may comprise one or more selected from the group consisting of metronidazole, permeth
  • skin penetration enhancing agents which benefit from the use of the present invention comprise one or more selected from the group consisting of solvents, surfactants, ethers, esters, fatty acid glycerides, urea, oleates, liposomes, retinoids, and occlusive compounds.
  • this treatment system incorporates a heat delivery patch or exothermic pad in combination with a holding member which maintains the heat delivery patch or exothermic pad in a precisely desired location where the particular medical problem is manifested or where heat delivery or a heat gradient is desired.
  • skin penetration enhancing agents and/or cosmetics may be integrated into the treatment system of this invention for further enhancement of its efficacy.
  • the wart virus is inactivated or slowed in its development, thereby preventing further invasion of the virus to adjacent tissue.
  • the normal reparative process of the skin takes effect, moving in the infected portion to a higher and higher level into the spinous layer of the epidermis, towards the surface of the skin, until the wart is shed in the normal process with the stratum corneum.
  • the temperature of the skin is elevated and maintained between about 39° to 44 °C, for periods of time ranging between about 1 and 10 hours.
  • the heat level to which the skin is exposed is maintained in a small, controlled range, which represents the optimum heat exposure for killing and inactivating the wart virus.
  • keratolytic chemical agents may be incorporated with and/or into the exothermic pad to assist in reducing the thickness of the epidermis, particularly the stratum corneum.
  • any removal of the outermost horny layer technically eliminates a portion of the wart as well as the viral particles contained therein, destroying the viral particles by shedding.
  • the thinning of the stratum corneum enables the heat to penetrate deeper within the wart lesion, thereby achieving greater efficacy from the application of the pad.
  • various keratolytic agents can be incorporated with and/or into the exothermic pad in order to reduce the upper layer of the epidermis, it has been found that salicylic acid or salicylic and lactic acid are preferable, since such chemicals may be incorporated with and/or into the exothermic pad to attain the desired beneficial results.
  • the exothermic pad may operate more effectively, since the thickness of the epidermis is reduced, thereby allowing the heat generated by the exothermic pad to penetrate the wart to a greater extent.
  • immune response modifiers such as interferon, imiquimod, DNCB, etc. may also be employed with equal efficacy.
  • the support member is specifically designed for being quickly and easily mountable to any location on an individual where a wart is normally found and remain in the precisely desired location in cooperating association with the heat delivery patch or exothermic pad.
  • the support member cooperates with the heat delivery patch or exothermic pad to securely maintain the patch/pad in direct association with the wart.
  • the support member of the present invention is also specifically constructed from material particularly designed for cooperating with a heat delivery patch or exothermic pad to synergistically interact therewith for assuring that the precisely required temperature levels are maintained and optimum oxygen flow is realized for the precisely desired period of time.
  • the support member forming the holding system of the present invention may be constructed in a variety of alternate configurations for providing the desired, quicky, easy, secure mounting thereof directly to any portion of the human anatomy where wart treatment is likely to be needed.
  • warts are most typically found on the extremities, thereby enabling the holding system of the present invention to comprise a construction which is quickly and easily mounted to an individual's hands, feet, toes, fingers, arms, forearms, legs, thighs, elbows, knees, head, and torso.
  • one preferred embodiment of the holding system of the present invention comprises a continuous, substantially cylindrically shaped tube member.
  • the holding system of the present invention is able to be easily mounted onto the hands, feet, arms, legs, etc. of the user, peripherally surrounding the hands, feet, arms or legs, and securely maintaining and cooperating with the pre-mounted exothermic pad or heat delivery patch in the precisely desired location.
  • alternate constructions can also be employed.
  • Such alternate constructions include cones, truncated cones, closed-end cylinders, and elongated strips of various sizes incorporating fastening means, such as snaps, velcro, adhesives, etc. mounted at opposed ends for securing the holding system in peripheral surrounding engagement with any desired area of the human anatomy.
  • fastening means such as snaps, velcro, adhesives, etc. mounted at opposed ends for securing the holding system in peripheral surrounding engagement with any desired area of the human anatomy.
  • tightening means preferably in the form of an elongated strip member mounted on the outside surface of the cylindrical holding system, can be employed in order to assure secure, snug, mounted engagement of the treatment system in the precisely desired location.
  • the material employed for forming the treatment system of this invention is the material employed for forming the treatment system of this invention.
  • most woven or non- woven materials are capable of being employed for forming the holding member.
  • the preferred material comprises an elastomer with its entirety or formed therein, in order to provide flexibility in easily mounting and securing the holding system in place.
  • the elastomer is integrally formed as a part of the material, such as a thermoplastic elastomer.
  • the preferred thermoplastic material comprises a foamed thermoplastic elastomer selected from the group consisting of polyurethane, polyolefins, polybutylenes, polyethylenes, polyesters, ethylene-propylene rubbers, polypropylenes, silicones, and vinyl based resins.
  • a foamed thermoplastic elastomer selected from the group consisting of polyurethane, polyolefins, polybutylenes, polyethylenes, polyesters, ethylene-propylene rubbers, polypropylenes, silicones, and vinyl based resins.
  • the temperature delivered directly to the wart by the exothermic pad or heat delivery patch is precisely controlled in a narrow range, for a determined length of time, due to the insulation provided by the holding system.
  • oxygen is circulated continuously through the holding system to provide proper operation of the exothermic pad/patch as well as provide air circulation to the surface of the skin being treated.
  • the invention accordingly comprises an article of manufacture possessing the features, properties, physical characteristics, qualities of the material being employed, and relation of elements which will be exemplified in the article hereinafter described and the scope of the invention will be indicated in the claims.
  • FIGURE 1 is a perspective view of one embodiment of the treatment system of the present invention with the holding member thereof mounted to a hand with an exothermic patch mounted to a finger of the hand;
  • FIGURE 2 is a perspective view of the holding member of FIGURE 1 ;
  • FIGURE 3 is a perspective view of an alternate construction of the holding member of the treatment system of the present invention.
  • FIGURE 4 is a perspective view of a further alternate embodiment of the holding member of the treatment system of the present invention.
  • FIGURE 5 is a perspective view of a still further alternate embodiment of the holding member of the treatment system of the present invention.
  • FIGURES 1-5 depict alternate preferred constructions for the treatment system of the present invention.
  • the embodiments are disclosed for exemplary purposes only, and are not intended as a limitation of the present invention. Consequently, alternate constructions and configurations for the system of the present invention can be made and are intended to be within this scope of the present invention.
  • treatment system 20 comprises a multi-component, fully integrated, easily employed construction for providing optimum delivery of heat therapy and/or a heat gradient to any desired location on the human anatomy for imparting medical benefits for a wide variety of various disorders and conditions.
  • treatment system 20 comprises holding member 21 and exothermic pad or heat delivery patch 28.
  • any desired drugs, skin penetration enhancing agents and/or cosmetics may also be combined as part of treatment system 20 in order to attain desired enhanced medicinal benefits.
  • the present invention achieves an extremely novel, fully integrated treatment system having broad applicability for a wide range of medical conditions.
  • the application of heat has been found to slow, inhibit, or reverse metabolic processes, immunological processes, or biological conditions or processes, which depend upon heat or are affected by heat.
  • broad applicability and extensive benefits are achieved by the present invention.
  • FIGURES 2-3 alternate, exemplary embodiments of holding member 21 of treatment system 20 are depicted.
  • one embodiment of treatment system 20 of the present invention is depicted as comprising a hollow, continuous, cylindrically shaped holding member 21 having an outer surface 22 and an inner surface 24.
  • holding member 21 may comprise any desired alternate size, shape, or configuration, and discussed herein.
  • treatment system 20 of the present invention in a manner which will provide controlled heating of any desired site where treatment is being sought, reference should be made to FIGURE 1.
  • FIGURE 1 the existence of a wart on finger 25 of hand 26 is depicted for exemplary purposes, with exothermic pad or heat delivery patch 28 mounted to finger 25 in overlying engagement with the wart formed thereon.
  • treatment system 20 of the present invention is placed about the fingers of hand 26, in overlying, secure, co-operative engagement with exothermic pad 28.
  • holding system 20 By securely mounting holding system 20 in overlying, cooperative engagement with heat delivery patch or exothermic pad 28, holding system 20 provides the desired co-operative association with pad/patch 28 to assure controlled heat delivery and oxygen circulation directly to the desired location. In this way, protection of the desired site is provided, along with control of the temperature to which the skin surface is exposed. As a result, the precisely desired temperature is delivered to the wart, within a desired, narrow range and for the precise length of time needed for killing the wart virus.
  • treatment system 20 of the present invention is also capable of treating other medical conditions such as psoriasis, skin cancers, leishmaniasis, mycobacteria, and granuloma annulare.
  • Each of these conditions can be treated or improved by heat penetration into the skin, subcutaneous tissues, joints, muscles, blood streams, etc.
  • the application of heat has been found to slow, inhibit, or reverse metabolic processes, immunological processes, or biological conditions or processes which depend upon heat or are affected by heat.
  • numerous medical conditions are effectively treated by employing the integrated treatment system of the present invention.
  • the use of heat produces a positive, synergistic effect on the targeted, controlled delivery of predetermined amounts of drugs, skin penetration enhancing agents, and/or cosmetics.
  • topical use of drugs, penetration enhancing agents, and/or cosmetics for the treatment of skin conditions and/or subcutaneous symptoms including, but not limited to, pain, itch, and irritations are improved or effectively treated by the use of the present invention.
  • the delivery of drugs, penetration enhancing agents and/or cosmetics through the skin for the purpose of achieving a non-oral and/or non- parenteral, systemic, transdermal delivery is effectively enhanced by the presence of a controlled heat gradient provided by the present invention.
  • a heat gradient as provided by the fully integrated treatment system of the present invention, is effective, in improving and enhancing the penetration of systemic and topical medications such as corticosteroids, chemotherapeutic agents, anesthetics, antihistamines, anti-infectives, anti-bacterials, anti-parasitics, anti-viral agents, anti-oxidants, immunomodulators, keratolytics, and anti-neoplasties.
  • systemic and topical medications such as corticosteroids, chemotherapeutic agents, anesthetics, antihistamines, anti-infectives, anti-bacterials, anti-parasitics, anti-viral agents, anti-oxidants, immunomodulators, keratolytics, and anti-neoplasties.
  • systemic and topical medications such as corticosteroids, chemotherapeutic agents, anesthetics, antihistamines, anti-infectives, anti-bacterials, anti-parasitics, anti-viral agents, anti
  • corticosteroids may comprise one or more selected from the group consisting of hydrocortisone, triamcinolone, and betamethasone and any other steroid commonly used in topical applications to the skin;
  • chemothera-peutic agents may comprise one or more selected from the group consisting of 5FU, Bleomycin, cytotoxic agents;
  • anesthetics may comprise one or more selected from the group consisting of lidocaine, prilocaine and pramoxine;
  • antihistamines may comprise one or more selected from the group consisting of diphenhydramine and its salts;
  • anti- infectives, such as anti-fungals may comprise one or more selected from the group consisting of clotrimazole and ciclopirox;
  • anti-bacterials may comprise one or more selected from the group consisting of gentamicin, tetracycline, erythromycin, and clindamycin;
  • anti-parasitics may comprise one or more selected from the group consisting of metronidazole, permet
  • skin penetration enhancing agents which benefit from the use of the present invention comprise one or more selected from the group consisting of solvents, surfactants, ethers, esters, fatty acid glycerides, urea, oleates, liposomes, retinoids, and occlusive compounds.
  • surfactants, including anionic surfactants may comprise one or more selected from the group consisting of sodium lauryl sulfate; surfactants, including non-ionic surfactants, may comprise one or more selected from the group consisting of laureth-4, polysorbates, poloxamers; surfactants, including cationic surfactants, may comprise one or more selected from the group consisting of stearylkonium chloride and benzalkonium chloride; ethers,
  • the present invention provides a treatment system for a wide variety of medical problems and conditions.
  • controlled delivery of heat therapy and/ or a heat gradient is provided to any desired location on the human anatomy for imparting medical benefits for a wide variety of various disorders and conditions.
  • both medicinal benefits and drug delivery are substantially enhanced.
  • the treatment system of the present invention comprises holding member 21 and exothermic pad or heat delivery patch 28, along with any desired drug, skin penetration enhancing agent and/or cosmetic which may be desired for combination therewith, as a part of treatment system 20.
  • holding member 21 may be formed in virtually any desired size or configuration.
  • FIGURES 1-5 depict preferred alternate configurations for holding member 21 of treatment system 20.
  • holding member 21 is depicted in FIGURES 1 and 2 as a hollow, continuous, cylindrically shaped member which is easily mountable to virtually any desired location on an extremity of an individual.
  • By constructing holding member 21 from various flexible materials an easy mounted construction is achieved, providing the precisely desired heat therapy and/or heat gradient in virtually any desired location.
  • woven or nonwoven materials can be employed for forming holding member 21.
  • holding member 21 may be constructed with elastomeric materials in order to provide further enhanced flexibility and mounting and securing ease.
  • holding member 21 is formed from thermoplastic elastomeric materials selected from the group consisting of polyurethanes, polyolefins, polybutylenes, polyethylenes, polyesters, ethylene- propylene rubbers, polypropylenes, silicones, and vinyl-based resins. Furthermore, by constructing holding member 21 from a foamed thermoplastic elastomer, any desired combination of closed cells and open cells is obtainable, with any desired ratio being provided. In this way, heat retention and/or insulation capabilities are achieved as an integral, inherent physical characteristic of holding member 21. In addition, by employing this construction, holding member 21 is able to transmit oxygen from the surrounding, ambient air directly to the location where the heat delivery patch or exothermic pad 28 is mounted.
  • FIGURE 1 depicts holding member 21 mounted about the hand of a user, peripherally surrounding all four fingers, with exothermic pad or heat delivery patch 28 mounted to finger 25 in aligned, overlying relationship with the area to be treated.
  • holding member 21 may comprise forwardly projecting portion 30 which extends forward of the fingertips of the user in order to allow the fingertips to be wrapped and enclosed, if desired.
  • rearwardly extending portion 31 is also depicted in FIGURE 1 for showing an elongated construction incorporating a thumb finger hole 32 formed therein for ease of application and mounting to the hand of an individual.
  • cylindrically shaped holding member 21 is depicted incorporating an optional securing strap 35 mounted to outer surface 22 thereof.
  • securing strap 35 may incorporate a wide variety of alternate constructions, in the preferred embodiment, strap 35 comprises a continuous, elongated member having opposed ends 36 and 37, with end 36 integrally bonded to outer surface 22 of holding member 21.
  • opposed end 37 of strap 35 is constructed for being securable to surface 22 in a wide variety of alternate locations.
  • fastening means are preferably formed adjacent end 37 of strap 35, positioned for cooperative interengagement with surface 22 of holding member 21.
  • any desired fastening means may be employed, such as adhesives, hook/loop fasteners, and the like.
  • strap 35 provides the desired securement of holding member 21 in the precisely desired location.
  • holding member 21 is mounted about the desired area to which the heat therapy or heat gradient is to be delivered and end 37 of strap 35 is removed from its initial engagement with surface 22 and moved into an alternate engaged location engage with surface 22 which provides the desired secure positioning of holding member 21 in the precisely desired location.
  • FIGURE 3 an alternate embodiment of holding member 21 of treatment system 20 of the present invention is depicted.
  • an elongated, substantially continuous sheet of material is employed which is easily wrapped about any desired location for peripherally surrounding an exothermic pad or heat delivery patch 28 mounted to the desired site.
  • fastening means 40 are formed on outer surface 22 of holding member 21, with cooperating fastening means 41 formed on inner surface 24 of holding member 21.
  • fastening means 40 and 41 are depicted as hook and loop fasteners, any alternate fastening means may be employed with equal efficacy.
  • holding member 21 may be constructed in any desired size and shape for enabling holding member 21 to be mounted to virtually any locations on the human anatomy.
  • treatment system 20 of the present invention can be effectively employed wherever needed for providing the desired heat therapy or heat gradient, as well as the enhanced delivery of any medicines, skin penetration enhancing agents, and/ or cosmetics.
  • holding member 21 of treatment system 20 of the present invention is depicted.
  • holding member 21 is constructed in a substantially continuous, hollow, truncated conical shaped.
  • this embodiment of holding member 21 may be constructed with securing strap 35 mounted to outer surface 22 thereof, as detailed above.
  • this embodiment of holding member 21 may also be constructed with an elongated slit formed in the outer surface thereof, as depicted in FIGURE 3, while also incorporating fastening means 40 and 41 formed on the surfaces thereof for enabling secure wrapped interengagement of holding member 21 to any desired location.
  • FIGURE 5 an alternate embodiment of holding member 21 of treatment system 20 of he present invention is depicted.
  • an elongated, substantially continuous sheet of material is employed which is quickly and easily affixed to any desired surface location on an individual for securely maintaining an exothermic paid or heat delivery patch 28 on the desired site.
  • adhesive means 45 are formed on inner surface 24 of holding member 21 , along at least two opposed edges. If desired, adhesive means 45 may be formed about the entire peripheral edge of surface 24 to assure secure affixation of holding member 21 to any surface of the body, without requiring peripheral surrounding of the body part.
  • fastening means 40 and 41 are depicted as hook and loop fasteners, any alternate fastening means may be employed with equal efficacy.
  • holding member 21 may be constructed in any desired size and shape for enabling holding member 21 to be mounted to virtually any location on the human anatomy.
  • treatment system 20 of the present invention can be effectively employed whenever needed for providing the desired heat therapy or heat gradient, as well as the enhanced delivery of any medicines, skin penetration enhancing agents, and/or cosmetics.
  • holding member 21 of treatment system 20 of the present invention may be configured in a wide variety of alternate constructions without departing from the scope of the present invention.
  • holding member 21 peripherally surrounds a pre-positioned exothermic pad or heat delivery patch 28 which has been mounted to the particular site where medicinal benefits are desired.
  • by also placing drugs, skin penetration enhancing agents and/or cosmetics on the site being treated further enhanced medicinal benefits may be achieved with treatment system 20 of this invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Heat Treatment Processes (AREA)

Abstract

Selon l'invention, on obtient un système de thermothérapie local, adapté au consommateur, pratique, facile à utiliser et destiné à de nombreux problèmes médicaux grâce à un élément de soutien intégré et facile d'utilisation, conçu uniquement pour coopérer avec une bande à émission de chaleur ou une plaquette exothermique afin d'optimiser l'application de chaleur directement à un emplacement précisément recherché. La présente invention concerne également un système de traitement entièrement intégré possédant de nombreuses conditions d'application pour plusieurs états pathologiques pouvant être traités ou soulagés par la pénétration de chaleur à travers la peau, les tissus sous-cutanés, les articulations, les muscles, le courant sanguin, etc. En outre, il a également été montré que l'administration par voie cutanée de médicaments, d'agents améliorant la pénétration dans la peau et/ou de cosmétiques, dans le but d'obtenir une administration transdermique systématique, non orale et/ou non parentérale, est améliorée efficacement par la présence d'un gradient thermique contrôlé.
PCT/US2001/003432 2000-02-08 2001-02-02 Medicament polyvalent et systeme de thermotherapie WO2001058408A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE60112248T DE60112248T2 (de) 2000-02-08 2001-02-02 Allzweck -medikament und -wärmebehandlungssystem
EP01908795A EP1255519B1 (fr) 2000-02-08 2001-02-02 Medicament et systeme de thermotherapie polyvalent
CA002398543A CA2398543A1 (fr) 2000-02-08 2001-02-02 Medicament polyvalent et systeme de thermotherapie
AU36627/01A AU778280B2 (en) 2000-02-08 2001-02-02 Multi-purpose drug and heat therapy treatment system
AT01908795T ATE300262T1 (de) 2000-02-08 2001-02-02 Allzweck -medikament und -wärmebehandlungssystem

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18104800P 2000-02-08 2000-02-08
US60/181,048 2000-02-08
US09/756,059 2001-01-08
US09/756,059 US20010049546A1 (en) 2000-02-08 2001-01-08 Multi-purpose drug and heat therapy treatment system

Publications (2)

Publication Number Publication Date
WO2001058408A2 true WO2001058408A2 (fr) 2001-08-16
WO2001058408A3 WO2001058408A3 (fr) 2002-03-07

Family

ID=26876845

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/003432 WO2001058408A2 (fr) 2000-02-08 2001-02-02 Medicament polyvalent et systeme de thermotherapie

Country Status (8)

Country Link
US (3) US20010049546A1 (fr)
EP (1) EP1255519B1 (fr)
AT (1) ATE300262T1 (fr)
AU (1) AU778280B2 (fr)
CA (1) CA2398543A1 (fr)
DE (1) DE60112248T2 (fr)
ES (1) ES2247064T3 (fr)
WO (1) WO2001058408A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3381419A1 (fr) 2017-03-30 2018-10-03 Trimb Healthcare AB Dispositif pour une thérapie thermique de troubles cutanés
CN109453460A (zh) * 2018-12-18 2019-03-12 河北鹊神生物科技有限公司 药石热敷灸基质、含有其的中药组合物及制备方法

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055475A1 (en) * 2001-09-17 2003-03-20 Rousmaniere Sharon O. Product and method for reduction of skin itch, discomfort, and disease
US8197526B2 (en) * 2003-05-09 2012-06-12 Kao Corporation Warming tool
EP1839705A1 (fr) 2006-03-27 2007-10-03 Universidad de Alcala Emplâtre cutané de thérapie laser
US8430921B2 (en) * 2008-05-15 2013-04-30 Wyeth Portable moist heat system
US8372130B2 (en) * 2009-01-23 2013-02-12 Forever Young International, Inc. Temperature controlled facial mask with area-specific treatments
EP2459132B1 (fr) 2009-07-26 2016-10-05 Forever Young International, Inc. Produits thermaux grand public auto-chauffants et leurs applications
US8523791B2 (en) * 2009-08-11 2013-09-03 Laboratoire Naturel Paris, Llc Multi-modal drug delivery system
WO2011095887A1 (fr) * 2010-02-04 2011-08-11 Americo Fernandes Dispositif de chauffage chimique et procédé pour le traitement de virus tels que l'herpès
CA2805664C (fr) 2010-07-23 2016-06-21 Avacen, Inc. Procedes et appareil pour application therapeutique d'energie thermique
KR101962658B1 (ko) 2010-11-04 2019-07-31 442 벤쳐스 엘엘씨 피부 상태를 치료하기 위한 조성물 및 방법
US9192509B2 (en) 2013-03-11 2015-11-24 Avacen, Inc. Methods and apparatus for therapeutic application of thermal energy including blood viscosity adjustment
US9687385B2 (en) 2013-03-11 2017-06-27 Avacen, Inc. Methods and apparatus for therapeutic application of thermal energy including blood viscosity adjustment
US20160242958A1 (en) * 2015-02-20 2016-08-25 Jamie Flora Thermotherapy devices for the ear
US20180014969A1 (en) * 2016-07-15 2018-01-18 Raymond K. Wurapa Assistive device for remediating inflammation, swelling and pain
US20180168855A1 (en) * 2016-12-15 2018-06-21 Penguin Fingers, Llc Joint compress cold pack
US11684282B2 (en) 2017-02-03 2023-06-27 Avacen, Inc. Systems and methods for evaluating blood circulation and early detection of cardiovascular issues
KR101953156B1 (ko) * 2018-11-15 2019-02-28 임하리 홍채를 이용한 건강 관리 방법 및 시스템
WO2023072861A1 (fr) * 2021-10-25 2023-05-04 Ellennbe Gmbh Composition pharmaceutique et kit comprenant une substance immunomodulatrice pour le traitement de maladies
WO2024084038A1 (fr) * 2022-10-20 2024-04-25 Ellennbe Gmbh Technologie de plateforme pour le traitement de maladies inflammatoires, immunologiques et/ou auto-immunologiques

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5697962A (en) * 1995-09-29 1997-12-16 Dura-Kold Corporation Therapeutic wrap
US5918590A (en) * 1995-06-29 1999-07-06 The Procter & Gamble Company Heat cells
US5935157A (en) * 1997-09-18 1999-08-10 Harmon; Susan Therapeutic cold pack for hand, wrist and forearm
US6013097A (en) * 1994-11-21 2000-01-11 Augautine Medical, Inc. Wound treatment device for attachment to skin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230105A (en) * 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
CA1149252A (fr) * 1980-04-09 1983-07-05 Anthony J. Last Bandage absorbeur de vibrations pour l'avant-bras
JPH01122037U (fr) * 1988-02-12 1989-08-18
US5986163A (en) * 1992-06-19 1999-11-16 Augustine Medical, Inc. Normothermic heater wound covering
US5534021A (en) * 1994-09-01 1996-07-09 Dvoretzky; Israel Heating pad for providing heat therapy
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5662096A (en) * 1995-07-03 1997-09-02 Omni Therm, Inc. Trigger to activate supercooled aqueous salt solution for use in a heat pack
US6245347B1 (en) * 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
DK0855888T3 (da) * 1995-10-03 2003-02-17 Tru Fit Marketing Corp Terapeutisk elastisk kropsstøtte
DE69908027T2 (de) * 1998-07-10 2004-04-08 Becton, Dickinson And Co. Ellbogenstütze mit bewegbarer Lasche

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013097A (en) * 1994-11-21 2000-01-11 Augautine Medical, Inc. Wound treatment device for attachment to skin
US5918590A (en) * 1995-06-29 1999-07-06 The Procter & Gamble Company Heat cells
US5697962A (en) * 1995-09-29 1997-12-16 Dura-Kold Corporation Therapeutic wrap
US5935157A (en) * 1997-09-18 1999-08-10 Harmon; Susan Therapeutic cold pack for hand, wrist and forearm

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1255519A2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3381419A1 (fr) 2017-03-30 2018-10-03 Trimb Healthcare AB Dispositif pour une thérapie thermique de troubles cutanés
CN109453460A (zh) * 2018-12-18 2019-03-12 河北鹊神生物科技有限公司 药石热敷灸基质、含有其的中药组合物及制备方法

Also Published As

Publication number Publication date
US20010049546A1 (en) 2001-12-06
ES2247064T3 (es) 2006-03-01
CA2398543A1 (fr) 2001-08-16
EP1255519A4 (fr) 2004-03-31
EP1255519B1 (fr) 2005-07-27
ATE300262T1 (de) 2005-08-15
US20040097864A1 (en) 2004-05-20
AU3662701A (en) 2001-08-20
EP1255519A2 (fr) 2002-11-13
DE60112248D1 (de) 2005-09-01
US20050208115A1 (en) 2005-09-22
WO2001058408A3 (fr) 2002-03-07
DE60112248T2 (de) 2006-05-24
AU778280B2 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
EP1255519B1 (fr) Medicament et systeme de thermotherapie polyvalent
US5534021A (en) Heating pad for providing heat therapy
JP4909892B2 (ja) 身体に治療をもたらすためのシステム及び方法
JP4669875B2 (ja) 身体の部位に治療をもたらすための互いに取外し可能に固定された２つのパッチの経皮システム
US6666836B1 (en) Thermal treatment system
AU2002248308B2 (en) Therapeutic film forming composition and treatment system
US7041124B2 (en) System and method for providing therapy to a portion of a body
US20080102108A1 (en) Therapeutic film forming composition and treatment system therefor
AU2006306563B2 (en) Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2005025467A1 (fr) Piece thermoreflechissante
US5053024A (en) Application system and method for treating warts
KR20070024177A (ko) 치료용 근육 고정 테이프 조성물
JP3343349B2 (ja) 発熱性パッド
EP3297587B1 (fr) Dispositif d'accès intraveineux
JPH04308526A (ja) 医療用貼付剤
IL98240A (en) Wart treatment system
MXPA06007295A (en) System and method for providing therapy to a portion of a body

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2398543

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 36627/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001908795

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001908795

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 36627/01

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2001908795

Country of ref document: EP